Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression
1 other identifier
interventional
16
1 country
1
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) has been recently FDA approved for the treatment of resistant depression. No accordance exists on which are the involved mechanisms of action and on which stimulation parameters, frequency and side are optimal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Sep 2008
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 8, 2008
CompletedFirst Posted
Study publicly available on registry
December 10, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2009
CompletedFebruary 24, 2011
February 1, 2011
4 months
December 8, 2008
February 23, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hamilton Depression Scale (HAM-D)
at baseline and 3rd week
Secondary Outcomes (1)
Clinical Global Impression Scale (CGI)
baseline and 3rd week
Study Arms (2)
1
ACTIVE COMPARATORpatients will undergo sequential bilateral rTMS treatment
2
ACTIVE COMPARATORpatients will undergo unilateral low frequency right sided DLPFC rTMS
Interventions
Repetitive TMS will be administered using a MAGSTIM rapid magnetic stimulator (Magstim Company, Ltd., Whitland, U.K.) and a 70-mm figure-eight shaped coils. In monolateral treatment in right DLPFC, three 140-second trains will be applied at 1 Hz and at 110% of RMT. There is a 30 seconds intertrain interval (total of 420 stimuli per session). In sequential treatment, the stimulation will be applied in the first to the right and then to the left dorsolateral prefrontal cortex. In right DLPFC will be applied three 140-second trains at 1 Hz and at 110% of RMT. There will be a 30 seconds intertrain interval (total of 420 stimuli per session). In left DLPFC will be applied twenty 5-second trains were applied at 10 Hz and at 100% of RMT. There will be a 25-second intertrain interval (total of 1000 stimuli per session). Patients will be treated from Monday to Friday, for a total of 15 days.
Patients will be treated from Monday to Friday, for a total of 15 days in the same timeframe of the active group right sided low frequency stimulation
Eligibility Criteria
You may qualify if:
- Diagnostic and Statistical Manual-IV criteria for Depressive Major Episode Hamilton Rating Scale for Depression -28 (Ham-D)score ≥ 18
- Failure to respond to a minimum of two courses of antidepressant medications for at least 6 weeks
You may not qualify if:
- Any comorbid axis I disorder (except simple and social phobia)
- Any other significant medical, particularly neurologic, illnesses (seizures, head trauma and brain lesions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Neuroscience
Florence, 50122, Italy
Related Publications (1)
Pallanti S, Bernardi S, Di Rollo A, Antonini S, Quercioli L. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience. 2010 May 5;167(2):323-8. doi: 10.1016/j.neuroscience.2010.01.063. Epub 2010 Feb 9.
PMID: 20144692DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefano Pallanti, md
Istituto di Neuroscienze
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 8, 2008
First Posted
December 10, 2008
Study Start
September 1, 2008
Primary Completion
January 1, 2009
Study Completion
January 1, 2009
Last Updated
February 24, 2011
Record last verified: 2011-02